查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1984209

核酸样品製备市场：按产品、工作流程类型、自动化程度、应用和最终用户划分－2026-2032年全球市场预测

Nucleic Acid Sample Preparation Market by Product, Workflow Type, Automation, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，核酸样品製备市场价值将达到 28.6 亿美元，到 2026 年将成长至 30.1 亿美元，到 2032 年将达到 42.1 亿美元，复合年增长率为 5.66%。

主要市场统计数据
基准年 2025 28.6亿美元
预计年份：2026年 30.1亿美元
预测年份 2032 42.1亿美元
复合年增长率 (%) 5.66%

了解核酸样品製备在实现可靠的分子工作流程和操作扩充性的策略性作用。

核酸样品製备生态系处于生命科学、临床诊断和工业生物技术的交汇点，是分子工作流程中关键预分析步骤的基础。提取化学、自动化和整合仪器的进步，已将样品製备从一项常规实验室任务提升为一项策略性环节，从而驱动下游流程的处理能力、可重复性和数据品质。随着定序、基于PCR的诊断和高内涵筛检对更高纯度核酸和更大样品处理能力的需求不断增长，样品製备阶段的选择对检测灵敏度、週转时间和操作效率有着至关重要的影响。

自动化、化学和检验的工作流程的创新如何重新定义样品製备实践和供应商生态系统。

近年来，核酸样本製备领域经历了变革性的变化，技术创新和不断变化的使用者需求重塑了供应商的策略和实验室的操作流程。自动化技术已从独立的机器人附加元件发展成为涵盖提取、纯化和品管步骤的整合平台，使实验室能够在不相应增加人工的情况下扩大操作规模。除了硬体的进步，化学技术的改进，例如结合能力更强的树脂和优化的裂解缓衝液，也减少了抑制剂的使用，提高了产量稳定性，并直接影响了下游检测的性能。

评估近期关税措施对样品製备价值链中的设备、试剂和製造地的营运和供应链影响。

美国贸易政策的转变以及2025年推出的关税措施，正给核酸样本製备领域的供应商和检查室客户带来微妙的营运压力。影响专用设备、进口试剂以及自动化萃取系统特定组件的关税，可能导致依赖全球供应链的检查室总体成本上升，并改变其筹资策略。为此，许多机构正在重新审视其采购流程，考虑供应商多元化，并增加关键耗材的安全库存，以降低短期波动风险。

我们分析产品、工作流程、应用程式、最终用户和自动化领域的趋势，以确定差异化的采用驱动因素和供应商定位机会。

透过从产品类型、工作流程类型、应用、最终用户和自动化等维度对市场进行细分，供应商和买家都能发现其中的潜在机会和限制。产品细分涵盖仪器、试剂盒、试剂和服务。仪器包括自动化萃取系统、离心机和真空歧管，以满足不同的处理能力和整合需求。试剂盒包括DNA萃取试剂盒、RNA萃取试剂盒和病毒核酸萃取试剂盒，这些试剂盒的设计旨在适应特定的样品基质和监管要求。试剂包括结合树脂、洗脱缓衝液、裂解缓衝液和洗涤缓衝液，这些试剂决定了纯度和产量特性。服务包括合约研究和客製化提取服务，为没有内部设施的机构提供柔软性。这些产品差异会影响采购决策、验证计画和供应商选择标准。

本检验了区域法规结构、采购实践和製造能力如何影响主要全球市场的采用趋势和供应商策略。

区域趋势对核酸样本製备领域的筹资策略、法规遵循和创新应用有显着影响。在美洲，市场对与临床诊断的整合、转化研究应用以及高通量自动化有着强劲的需求，而采购週期通常与医保报销政策和公共卫生优先事项紧密相关。这为经过验证的试剂盒和整合仪器平台提供了有利环境，尤其是在结合可靠的技术支援和严格的法规文件时。此外，该地区各国法规结构的差异也会影响诊断工作流程的实施时间。

透过平台互通性、检验的耗材、服务能力和永续性措施来评估竞争差异化。

核酸样本製备领域的竞争趋势是由技术差异化、丰富的耗材产品组合以及提供端到端检验工作流程的能力共同驱动的。领先的仪器製造商透过平台间的互通性、可扩展的扩充性以及能够减少临床和高通量研究客户停机时间的服务网络来脱颖而出。试剂盒和试剂供应商则在与主流仪器的整合便捷性、对多种检体类型的稳健性以及由临床和研究用例支援的检验资料强度方面展开竞争。包括合约研究组织 (CRO) 和客製化提取实验室在内的服务供应商，透过提供针对特定检体类型的检验流程和快速週转时间，正在开闢独特的细分市场。

为供应商和检查室管理人员提供切实可行的策略，以加快部署速度，降低供应链风险，并使经营模式与客户工作流程保持一致。

产业领导企业可以透过推进一系列目标明确、切实可行的倡议，将不断变化的市场动态转化为策略优势。首先，优先考虑模组化平台设计和开放原始码互通性，可以拓展可用用例范围，缓解买家对供应商锁定的担忧，并最终扩大商业性覆盖率。其次，投资检验的端到端工作流程和完善的技术文檔，可以加快客户导入速度，缩短价值实现时间，这对临床检查室客户尤其重要。第三，分散生产和采购地点，可以降低关税带来的成本压力，同时增强应对市场干扰的能力。

严格的混合研究通讯协定，结合了对从业人员的访谈、技术文献、监管趋势分析和交叉检验，确保了对该行业的深刻洞察。

本分析的研究途径结合了第一手和第二手调查，以确保对主题调查结果进行三角检验。第一手调查资料包括对临床检查室营运经理、学术机构采购经理、受託研究机构技术经理以及设备和试剂供应商产品经理的结构化访谈。这些访谈重点在于实际应用中的挑战、检验的考虑因素以及采购优先事项。第二手数据包括关于萃取化学的同行评审文献、与临床诊断相关的监管指导文件、展示创新路径的专利申请以及设备供应商的技术手册，以了解其整合能力。

自动化、经过验证的耗材和强大的采购系统相结合，整合了提高分子检测性能的策略要求。

核酸样本製备在分子诊断生态系统中扮演着至关重要的角色，提取化学、自动化和经验证的工作流程的改进将直接影响诊断灵敏度、检测可重复性和操作效率。该领域的发展趋势将继续受到技术整合的影响，包括整合到平台中的硬体、耗材和软体，以及受区域法规、关税环境和机构优先事项驱动的采购行为转变。能够使其产品蓝图与客户面临的挑战（例如检验时间、供应可靠性和整体拥有成本）相符的供应商，将更有利于确保持续的需求。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：核酸样品製备市场：依产品划分

  • 装置
    • 自动提取装置
    • 离心机
    • 真空歧管
  • 成套工具
    • DNA萃取试剂盒
    • RNA萃取试剂盒
    • 病毒核酸萃取试剂盒
  • 试剂
    • 黏合树脂
    • 洗脱缓衝液
    • 溶解缓衝液
    • 洗涤缓衝液
  • 服务
    • 合约研究
    • 客製化提取服务

第九章：依工作流程类型分類的核酸样品製备市场

  • DNA萃取
    • 列式法
    • 磁珠法
    • 有机萃取
  • 微生物萃取
    • 化学溶解
    • 机械溶解
  • 质体萃取
    • 碱溶解
    • SDS法
  • 病毒核酸萃取

第十章：核酸样品製备市场：自动化驱动

  • 全自动
  • 手动的
  • 半自动

第十一章：核酸样品製备市场：依应用领域划分

  • 临床诊断
  • 药物发现与开发
  • 法医学分析
  • 基因组调查
  • 个人化医疗

第十二章 核酸样品製备市场：依最终用户划分

  • 学术研究机构
  • 临床检查室
  • 法医学研究所
  • 工业研究院
  • 製药和生物技术公司

第十三章：核酸样品製备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：核酸样品製备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 核酸样品製备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国核酸样品製备市场

第十七章：中国核酸样品製备市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agilent Technologies, Inc.
  • Aurora Biomed Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Bionano Genomics
  • BIONEER CORPORATION
  • Blue-Ray Biotech Corp.
  • Danaher Corporation
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd
  • Hamilton Company
  • Illumina, Inc.
  • LGC Biosearch Technologies
  • Merck KGaA
  • MP Biomedicals, LLC
  • Nanjing Vazyme Biotech Co.,Ltd.
  • Norgen Biotek Corp.
  • Opentrons Labworks, Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN NV
  • RevoluGen Ltd
  • Sansure Biotech Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-5C6F41F5B02F

The Nucleic Acid Sample Preparation Market was valued at USD 2.86 billion in 2025 and is projected to grow to USD 3.01 billion in 2026, with a CAGR of 5.66%, reaching USD 4.21 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.86 billion
Estimated Year [2026] USD 3.01 billion
Forecast Year [2032] USD 4.21 billion
CAGR (%) 5.66%

Understanding the strategic role of nucleic acid sample preparation in enabling reliable molecular workflows and operational scalability

The nucleic acid sample preparation ecosystem sits at the intersection of life sciences, clinical diagnostics, and industrial biotechnology, serving as the essential pre-analytical backbone for molecular workflows. Advances in extraction chemistry, automation, and integrated instruments have elevated sample prep from a routine laboratory task to a strategic enabler of throughput, reproducibility, and downstream data quality. As sequencing, PCR-based diagnostics, and high-content screening continue to demand purer nucleic acids and higher sample throughput, the choices made at the sample preparation stage materially influence assay sensitivity, turnaround time, and operational efficiency.

Stakeholders across academic research, clinical labs, forensic units, and biopharma development are increasingly evaluating sample preparation through the twin lenses of scalability and compliance. This shift reflects broader industry priorities including rapid diagnostic readiness, reproducible research, and cost-effective platform deployment. Consequently, vendors and end users alike are investing in modular instrument platforms, validated kits, and standardized protocols that reduce variability. The narrative of nucleic acid sample preparation is therefore not static; it is a dynamic field driven by technological refinement, evolving regulatory expectations, and expanding application domains that together set the context for strategic decisions in procurement, R&D, and clinical deployment.

How innovations in automation, chemistry, and validated workflows are redefining sample preparation practices and vendor ecosystems

Recent years have seen transformative shifts across the nucleic acid sample preparation landscape, where technological innovation and changing user demands converge to reshape vendor strategies and laboratory practices. Automation has moved beyond single-use robotic add-ons to integrated platforms that combine extraction, purification, and quality control steps, enabling laboratories to scale without proportionate increases in hands-on time. Parallel to hardware evolution, chemistry improvements such as enhanced binding resins and optimized lysis buffers have reduced inhibitory substances and improved yield consistency, directly impacting downstream assay performance.

Another important shift is the proliferation of workflow-specific kits and validated protocols tailored to sample types and regulatory environments. This trend has been driven by the need for reproducibility in clinical diagnostics and the demand for plug-and-play solutions in decentralized testing environments. Additionally, the rise of magnetic bead-based methods as a default for many workflows has prompted a reassessment of consumable supply chains, with users seeking multi-vendor compatibility and open-platform reagents. Taken together, these changes are creating a more modular, interoperable ecosystem where rapid deployment and protocol standardization are prioritized alongside raw performance.

Assessing the operational and supply chain ramifications of recent tariff actions on instruments, reagents, and manufacturing footprints within the sample preparation value chain

Policy shifts and tariff measures introduced in 2025 within United States trade policy have introduced nuanced operational pressures for suppliers and laboratory customers involved in nucleic acid sample preparation. Tariffs that affect specialized instruments, imported reagents, and certain components used in automated extractors have the potential to increase landed costs and alter sourcing strategies for laboratories that rely on global supply chains. In response, many organizations are reassessing their procurement footprints, exploring diversified supplier panels, and increasing safety stock for critical consumables to mitigate near-term volatility.

Beyond procurement, tariff-related changes can accelerate regionalization trends as manufacturers evaluate the trade-offs between centralized production and localized manufacturing to preserve cost competitiveness. This has implications for lead times, quality control frameworks, and regulatory compliance, particularly where local production requires new validation steps or changes in reagent formulations. Importantly, the cumulative impact of tariffs extends to contract research providers and service laboratories that operate on thin margins; these entities may pass increased costs downstream or renegotiate service contracts to maintain viability. In sum, trade policy developments are prompting a strategic recalibration across the value chain, characterized by supply diversification, manufacturing localization, and revised inventory management practices.

Parsing product, workflow, application, end user, and automation segment dynamics to reveal differentiated adoption drivers and vendor positioning opportunities

Deconstructing the market along product, workflow type, application, end user, and automation axes reveals nuanced opportunities and constraints for vendors and buyers alike. Product segmentation spans instruments, kits, reagents, and services, where instruments encompass automated extractors, centrifuges, and vacuum manifolds that address different throughput and integration needs; kits include DNA extraction kits, RNA extraction kits, and viral nucleic acid extraction kits designed for specific sample matrices and regulatory demands; reagents consist of binding resins, elution buffers, lysis buffers, and wash buffers that determine purity and yield characteristics; and services cover contract research and custom extraction services that provide flexibility for organizations without in-house capacity. These product distinctions inform purchasing decisions, validation timelines, and vendor selection criteria.

Workflow segmentation further differentiates market needs across DNA extraction, microbial extraction, plasmid extraction, RNA extraction, and viral nucleic acid extraction. Each workflow contains method-specific subtypes-such as column-based, magnetic bead-based, and organic extraction for DNA and RNA; chemical lysis and mechanical lysis for microbial extraction; and alkaline lysis or SDS-based methods for plasmid extraction-that influence consumable compatibility, automation potential, and assay sensitivity. Application-driven demand emerges across clinical diagnostics, drug discovery and development, forensic analysis, genomic research, and personalized medicine, each placing distinct regulatory, throughput, and quality requirements on sample prep choices. End users range from academic research laboratories and clinical laboratories to forensic and industrial labs, as well as pharmaceutical and biotechnology companies, with adoption patterns shaped by budget cycles, accreditation needs, and throughput expectations. Finally, automation tiers-fully automated, manual, and semi-automated-define the balance between capital expenditure and labor savings, shaping total cost of ownership considerations and influencing the pace at which labs adopt new platforms.

Examining how regional regulatory frameworks, procurement behaviors, and manufacturing capacity shape adoption and vendor strategy across major global markets

Regional dynamics significantly influence procurement strategies, regulatory compliance, and innovation adoption within the nucleic acid sample preparation space. The Americas demonstrate a strong emphasis on clinical diagnostics integration, translational research applications, and an appetite for high-throughput automation, with procurement cycles often tied to reimbursement policies and public health priorities. This creates an environment where validated kits and integrated instrument platforms gain traction, especially when coupled with reliable technical support and rigorous regulatory documentation. Comparative regulatory frameworks across countries within the region also affect time-to-deployment for diagnostic workflows.

Europe, Middle East & Africa present a heterogeneous landscape where regulatory harmonization in parts of Europe coexists with variable market maturity across the Middle East and Africa. Buyers in this region prioritize vendor support, CE-marked or regionally certified solutions, and flexible supply arrangements that account for cross-border logistics challenges. Localized training and language-specific documentation frequently influence vendor selection. The Asia-Pacific region is characterized by rapid capacity expansion, strong manufacturing capabilities, and a mixed adoption curve where cutting-edge academic centers coexist with emerging clinical markets. Here, cost-sensitive procurement coexists with aggressive adoption of automation and domestic reagent production, prompting international vendors to adapt commercial strategies to local price points and partnership models.

Evaluating competitive differentiation through platform interoperability, validated consumables, service capabilities, and sustainability commitments

Competitive dynamics in nucleic acid sample preparation are influenced by a combination of technological differentiation, breadth of consumable portfolios, and the ability to provide end-to-end validated workflows. Leading instrument manufacturers differentiate through platform interoperability, throughput scaling, and service networks that reduce downtime for clinical and high-throughput research customers. Kit and reagent suppliers compete on ease of integration with popular instruments, robustness across sample types, and the strength of validation data supporting clinical or research use cases. Service providers, including contract research organizations and custom extraction labs, carve niches by offering validated pipelines and rapid turnaround times for specialized sample types.

Strategic partnerships and cross-licensing arrangements between instrument vendors and reagent developers are frequent, enabling faster market entry for complete solutions and helping laboratories shorten validation timelines. Additionally, an increasing number of companies are investing in application support teams and training programs to reduce adoption friction, particularly for buyers transitioning from manual to automated workflows. Sustainability considerations, such as reduced plastic waste and recyclable consumables, are beginning to influence procurement choices and product development roadmaps, adding an additional dimension to competitive positioning.

Actionable strategies for vendors and laboratory leaders to accelerate adoption, de-risk supply chains, and align commercial models with customer workflows

Industry leaders can convert shifting market dynamics into strategic advantage by pursuing a set of focused, actionable initiatives. First, prioritizing modular platform design and open-source interoperability increases addressable use cases and reduces buyer reluctance around vendor lock-in, thereby expanding commercial reach. Second, investing in validated end-to-end workflows and robust technical documentation accelerates customer onboarding and shortens time-to-value, which is particularly important for clinical laboratory customers. Third, diversifying manufacturing and sourcing footprints mitigates exposure to tariff-driven cost pressures while improving resilience against disruption.

Beyond product and supply considerations, leaders should enhance commercial propositions through flexible pricing models, including reagent leasing, pay-per-test arrangements, and bundled service offerings that align with customers' operational budgets. Strengthening regional support networks and localized training initiatives will improve adoption rates in diverse regulatory environments, while targeted partnerships with clinical and academic centers can generate high-quality validation data and practitioner advocacy. Finally, embedding sustainability targets into product design and consumable lifecycle planning can differentiate vendors with forward-looking procurement mandates and help organizations align with institutional ESG objectives.

A rigorous mixed-methods research protocol combining practitioner interviews, technical literature, regulatory review, and cross-validation to ensure robust industry insights

The research approach underpinning this analysis combined primary and secondary methods to ensure triangulation and validation of thematic findings. Primary inputs included structured interviews with operational leaders in clinical laboratories, procurement managers at academic institutions, technical directors at contract research providers, and product managers at instrument and reagent suppliers. These engagements focused on real-world adoption challenges, validation considerations, and procurement priorities. Secondary inputs comprised peer-reviewed literature on extraction chemistries, regulatory guidance documents relevant to clinical diagnostics, patent filings that highlight innovation trajectories, and technical manuals from instrument vendors to understand integration capabilities.

Qualitative synthesis was complemented by cross-validation steps, where vendor claims about throughput and compatibility were contrasted against independent user testimony and regulatory documentation. Attention was paid to recent public policy changes affecting trade and tariffs to contextualize supply chain implications. Throughout the process, potential biases were managed by anonymizing primary respondent data and seeking multiple confirmations for critical assertions, resulting in a robust, practitioner-focused body of evidence that supports the strategic insights presented in this report.

Synthesizing strategic imperatives where automation, validated consumables, and resilient sourcing converge to enhance molecular assay performance

Nucleic acid sample preparation occupies a pivotal role in the molecular ecosystem, where improvements in extraction chemistry, automation, and validated workflows directly influence diagnostic sensitivity, research reproducibility, and operational throughput. The landscape will continue to be shaped by technological convergence-platforms that integrate hardware, consumables, and software-alongside shifting procurement behaviors driven by regional regulations, tariff environments, and institutional priorities. Vendors that align product roadmaps with customer pain points such as validation time, supply reliability, and total cost of ownership will be best positioned to capture durable demand.

For laboratories and corporate buyers, the imperative is to balance near-term operational resilience with strategic investments in automation and validated consumables that support future assay expansion. Building supplier diversity into sourcing strategies, engaging in collaborative validation exercises with vendors, and demanding transparent technical evidence will reduce deployment friction and enhance assay reliability. Taken together, these steps will enable organizations to harness the full potential of advances in sample preparation and translate them into measurable improvements in downstream molecular outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nucleic Acid Sample Preparation Market, by Product

  • 8.1. Instruments
    • 8.1.1. Automated Extractors
    • 8.1.2. Centrifuges
    • 8.1.3. Vacuum Manifolds
  • 8.2. Kits
    • 8.2.1. Dna Extraction Kits
    • 8.2.2. Rna Extraction Kits
    • 8.2.3. Viral Nucleic Acid Extraction Kits
  • 8.3. Reagents
    • 8.3.1. Binding Resins
    • 8.3.2. Elution Buffers
    • 8.3.3. Lysis Buffers
    • 8.3.4. Wash Buffers
  • 8.4. Services
    • 8.4.1. Contract Research
    • 8.4.2. Custom Extraction Services

9. Nucleic Acid Sample Preparation Market, by Workflow Type

  • 9.1. Dna Extraction
    • 9.1.1. Column Based
    • 9.1.2. Magnetic Bead Based
    • 9.1.3. Organic Extraction
  • 9.2. Microbial Extraction
    • 9.2.1. Chemical Lysis
    • 9.2.2. Mechanical Lysis
  • 9.3. Plasmid Extraction
    • 9.3.1. Alkaline Lysis
    • 9.3.2. SDS Based
  • 9.4. Viral Nucleic Acid Extraction

10. Nucleic Acid Sample Preparation Market, by Automation

  • 10.1. Fully Automated
  • 10.2. Manual
  • 10.3. Semi Automated

11. Nucleic Acid Sample Preparation Market, by Application

  • 11.1. Clinical Diagnostics
  • 11.2. Drug Discovery And Development
  • 11.3. Forensic Analysis
  • 11.4. Genomic Research
  • 11.5. Personalized Medicine

12. Nucleic Acid Sample Preparation Market, by End User

  • 12.1. Academic Research Laboratories
  • 12.2. Clinical Laboratories
  • 12.3. Forensic Laboratories
  • 12.4. Industrial Laboratories
  • 12.5. Pharmaceutical And Biotechnology Companies

13. Nucleic Acid Sample Preparation Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Nucleic Acid Sample Preparation Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Nucleic Acid Sample Preparation Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Nucleic Acid Sample Preparation Market

17. China Nucleic Acid Sample Preparation Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agilent Technologies, Inc.
  • 18.6. Aurora Biomed Inc.
  • 18.7. BGI Group
  • 18.8. Bio-Rad Laboratories, Inc.
  • 18.9. Bionano Genomics
  • 18.10. BIONEER CORPORATION
  • 18.11. Blue-Ray Biotech Corp.
  • 18.12. Danaher Corporation
  • 18.13. Eppendorf SE
  • 18.14. F. Hoffmann-La Roche Ltd
  • 18.15. Hamilton Company
  • 18.16. Illumina, Inc.
  • 18.17. LGC Biosearch Technologies
  • 18.18. Merck KGaA
  • 18.19. MP Biomedicals, LLC
  • 18.20. Nanjing Vazyme Biotech Co.,Ltd.
  • 18.21. Norgen Biotek Corp.
  • 18.22. Opentrons Labworks, Inc.
  • 18.23. PerkinElmer Inc.
  • 18.24. Promega Corporation
  • 18.25. QIAGEN N.V.
  • 18.26. RevoluGen Ltd
  • 18.27. Sansure Biotech Inc.
  • 18.28. Tecan Trading AG
  • 18.29. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED EXTRACTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED EXTRACTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED EXTRACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VACUUM MANIFOLDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VACUUM MANIFOLDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VACUUM MANIFOLDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY BINDING RESINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY BINDING RESINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY BINDING RESINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ELUTION BUFFERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ELUTION BUFFERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ELUTION BUFFERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY LYSIS BUFFERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY LYSIS BUFFERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY LYSIS BUFFERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WASH BUFFERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WASH BUFFERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WASH BUFFERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CHEMICAL LYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CHEMICAL LYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CHEMICAL LYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL LYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL LYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL LYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ALKALINE LYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ALKALINE LYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ALKALINE LYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SDS BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SDS BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SDS BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SEMI AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SEMI AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INDUSTRIAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INDUSTRIAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INDUSTRIAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 255. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 256. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 257. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 258. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 259. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 261. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 262. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 263. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 264. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. G7 NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 293. G7 NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (